MK-4716
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 18, 2026
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)
(clinicaltrialsregister.eu)
- P1/2 | N=29 | Recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1/2 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
December 31, 2025
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
(clinicaltrials.gov)
- P1 | N=250 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Oncology • Solid Tumor
November 26, 2025
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
(clinicaltrials.gov)
- P1 | N=250 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1